 Effects converting-enzyme inhibition barrier function diabetic glomerulopathy Differential solute clearances effects course enalapril glomerular barrier function proteinuric patients diabetic glomerulopathy day plasma renin prorenin elevated arterial pressure Transglomerular passage dextrans broad size distribution radii subset patients withdrawal enalapril additional days return renin levels arterial pressure pretreatment levels dextran-sieving profile levels theoretical analysis serial dextran-sieving profiles enalapril glomerular pore size distribution size changes barrier size selectivity reduction fractional albumin IgG clearances enalapril therapy subsequent rise quantities withdrawal urinary protein excretion rate parallel inhibition enzyme humans diabetic glomerulopathy diminishes glomerular permeability proteins size selectivity enalapril therapy withdrawal glomerular filtration renal plasma flow rates primary action enalapril intrinsic membrane properties glomerular barrier